U.S. Stem Cell, Inc.
U.S. Stem Cell, Inc. (USRM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · USRM · as of Jun 9, 2026
Key Statistics
Explore U.S. Stem Cell, Inc. Data
usrm stock data · financialsCompetitors & Peers
usrm competitorsUSRM
AVXT
BRAXF
BSSP
DNAG
IPAHAbout U.S. Stem Cell, Inc.
U.S. Stem Cell, Inc. is a biotechnology firm dedicated to the advancement and commercialization of autologous cellular therapies throughout the United States. Its core mission is to address a range of…
what is u.s. stem cell, inc. · usrm stock overview · u.s. stem cell, inc. company profile · who is u.s. stem cell, inc. ceo · usrm OTC · u.s. stem cell, inc. headquarters · u.s. stem cell, inc. business segments
About Stock Overview & Key Data
U.S. Stem Cell, Inc. (USRM) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 19, 2008. As of the latest trading session, USRM stock price is $0.00, with a market capitalization of $64,151. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, U.S. Stem Cell, Inc. (USRM) stock price is $0.00. The stock is traded on OTC under the ticker symbol USRM. The 52-week range is $0.00 – $0.00.